BackSeelos Therapeutics Overview

Seelos Therapeutics Selling, General & Admin

Selling, General & Admin expenses for SEEL.

Quarterly SG&A Expenses

$2.53M
↓ 8.85% YoY

As of Jun 30, 2024

Annual SG&A Expenses (TTM)

$11.35M
↓ 7.49% YoY

Trailing 12 months ending Jun 30, 2024

Average SG&A Expenses (Comparison Companies)

Selling, General & Admin History

Selling, General & Admin Comparison

Annual Selling, General & Admin Growth Rate (%)

Annual Selling, General & Admin Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin